Browse products
Business strategies of pharma makers from Central and Eastern Europe 2007Acquisition prospects and development forecasts |
Our clients say...
The report Business strategies of pharma makers from Central and Eastern Europe 2007 from PMR profiles the most prospective indigenous pharmaceutical manufacturers in Central and Eastern European (CEE) countries. As potential acquisition targets for both multinationals and regional players, a critical examination of their performance and growth strategies, from operations to branding, provides invaluable intelligence necessary in a rapidly developing market.
“Sanofi-Aventis group regularly order PMR's reports and newsletters concerning the Polish pharmaceutical market. We use PMR's services because of the wealth of experience of its analysts in undertaking market analysis and a high level of quality and involvement in the field of market research. ”
General Manager, Sanofi-Synthelabo
“PMR reports are a serious contribution to the market overview picture, focusing our attention on key events in the industry as well as highlighting both general and specific market indicators. Together, these components are the base for our future forecasts of construction market development and help us to plan our sales.
”
Market Analyst, Alpha Cement
“We consider PMR a competent and professional company. PMR analysts understand our needs clearly and their services have fully met our expectations. I strongly recommend the company as a reliable partner in providing economic information and market analysis.”
General Manager, Sanofi-Synthelabo
“It's a great pleasure to cooperate with PMR because of its analysts' wealth of experience in understanding the local market. We consider PMR a competent and professional company which helps us conduct our business. I would also like to state that PMR's team is always ready to respond to emerging customer needs. We can recommend it as a reliable partner.”
Business Analyst, Hilti Distribution, Russia
“As a London-based company, with operations abroad, we looked for the best-in-class Market Intelligence supplier. PMR brought us quality reports that improved our CEE market knowledge and understanding.”
Development Manager, GVA Grimley
“PMR provides a good service and is always open to discussion. All reports are well structured & are always on time.”
Member of the Managment Board, SCA Hygiene Products
“PMR's analysts understand our needs well and the standard of their service has always fully met our expectations. We are looking forward to cooperating with PMR in the future as well. ”
Senior Trade and Investment Adviser, British Embassy in Warsaw
“We use PMR's services due to their analysts' extensive experience in market analysis, their high quality and level of engagement in the market research carried out for us. We consider PMR a competent and professional company and recommend them as a reliable partner in the area of economic information and market analysis.”
Senior Trade and Investment Adviser, British Embassy in Warsaw
These companies including Gedeon Richter, Krka, Polpharma, Sanitas and Zentiva are on the brink of next phase development, either through acquisition of smaller firms or merger with larger organisations. With a dynamically changing market regionally and globally, this report performs essential analysis on their various strengths, weaknesses, opportunities and threats.
Key sections
- Executive summary
- Macro-economic overview of the region
- Summary of market development
- Indigenous Central and Eastern European pharmaceutical manufacturers’ strategies
- Potential acquisition targets
- Potential predators
An essential read for:
- top managers, strategic planners and executives of companies considering entry or active in or interested in entering the Central and Eastern European market
- companies engaged in manufacturing, distributing and importing pharmaceuticals
- key decision makers and consultants involved in the healthcare industry
- multinational giants interested in acquisition within Central and Eastern Europe and potential competitors in the region
- regional players investigating successful growth strategies of their competitors or looking to be acquired.
This report is an invaluable resource for any company considering merger and acquisitions in the Central and Eastern European healthcare and pharmaceuticals market.
Request sample pages/interactive screenshare
-
Report methodology
-
Basic economic and health indicators in CEE in 2006
-
Overview of the CEE pharmaceutical market
- CEE market value
- Generic and innovative drugs in CEE
- The largest pharmaceutical companies
- Russia
- General overview of the market
- Manufacturers
- Distributors
- Poland
- General overview of the market
- Manufacturers
- Distributors
- Czech Republic
- General overview of the market
- Manufacturers
- Distributors
- Hungary
- General overview of the market
- Manufacturers
- Distributors
- Romania
- General overview of the market
- Manufacturers
- Distributors
- Ukraine
- General overview of the market
- Manufacturers
- Distributors
- Bulgaria
- General overview of the market
- Manufacturers
- Distributors
- Croatia
- General overview of the market
- Manufacturers
- Distributors
- Slovakia
- General overview of the market
- Manufacturers
- Distributors
- Slovenia
- General overview of the market
- Manufacturers
- Distributors
- Lithuania
- General overview of the market
- Manufacturers
- Distributors
- Latvia
- General overview of the market
- Manufacturers
- Distributors
- Estonia
- General overview of the market
- Manufacturers
- Distributors
- Belarus
- General overview of the market
- Manufacturers
- Serbia
- General overview of the market
- Manufacturers
-
CEE pharmaceutical market development since 2004
- Drug market development in Central
- Eastern Europe
- Recent trends on CEE pharmaceutical market
- Russia - a separate example of development
- Impact of cost-cutting policies on
- CEE pharmaceutical market
- Anticipated future trends on CEE pharmaceutical market
- The rise of generics in Central and Eastern Europe
- Evolution of CEE generics market
- Key growth drivers and inhibitors of CEE generics market
- Development of branded generics market in CEE
- CEE pharmaceutical market consolidation
- Drug market development in Central
-
Business strategies of CEE pharma makers
- Comparison of analysed manufacturers
- Gedeon Richter
- Overview
- SWOT
- Market coverage
- Operating strategies
- Brand strategy
- Financials
- Forecast
- Krka
- Overview
- SWOT
- Market coverage
- Operating strategies
- Brand strategy
- Financials
- Forecast
- Zentiva
- Overview
- SWOT
- Market coverage
- Operating strategies
- Brand strategy
- Financials
- Forecast
- Polpharma
- Overview
- SWOT
- Market coverage
- Operating strategies
- Brand strategy
- Financials
- Forecast
- Sanitas
- Overview
- SWOT
- Market coverage
- Operating strategies
- Brand strategy
- Financials
- Forecast
-
Potential acquisition targets in emerging CEE markets
- Introduction
- Romania
- Antibiotice
- LaborMed Pharma
- Biofarm
- Russia
- Pharmstandart
- Otechestvennye Lekarstva
- Ukraine
- Darnitsa, Arterium and Farmak
- Belarus
- Borisovsky Plant and Belmedpreparaty
-
Potential predators of indigenous CEE pharmaceutical manufacturers
- Actavis
- Stada AG
- GlaxoSmithKline
- Sanofi-Aventis
- Novartis
- Teva
- Ranbaxy
-
List of graphs
-
List of tables
List of graphs
- CEE market value by country, 2006
- Year-on-year growth of CEE pharma markets, by value, 2006
- Share of generics in pharmaceutical market in CEE countries, by value, 2006
- Russian pharmaceutical market’s value versus per capita drug consumption ($), 1996-2012
- Top 10 pharma manufacturers on the Russian market (market share by value, %), 2006
- Top 10 pharma concerns on the Polish pharmacy market (% of pharmacy sales), 2006
- The largest pharmaceutical wholesale in Poland, 2007
- Top 10 pharma manufacturers on the Hungarian market (market share by value, %), Q1 2007
- Top 10 pharma manufacturers in on the Romanian market (market share by value, %), March 2007
- Leading players by revenues on the Romanian drug market (€ m), MAT Q1 2007
- Top 10 pharma manufacturers on the Ukrainian market (market share by value, %), H1 2007
- Top 10 pharmaceutical wholesalers on the Ukrainian market (market share by value, %), 2005
- The largest pharmaceutical wholesalers in Lithuania, 2007
- The largest pharmaceutical wholesalers in Estonia, 2006
- Top 10 pharma manufacturers on the Belarus retail pharmaceutical market (market share by value, %), H1 2007
- Top 10 pharmaceutical wholesalers on the Serbian market (market share by value, %), 2005
- Serbia: leading pharmaceutical import partners ($ m), 2004
- Selected CEE pharma manufacturers’ sales growth (% LC terms), 2003-2006
- Gedeon Richter, sales by region (%), 2006
- Gedeon Richter, sales by leading product areas (%), 2006
- Gedeon Richter, sales value (HUF) and growth (%), 2002-2006
- Krka, sales by region (%), 2006
- Krka, revenue by business operations (%), 2006
- Krka, sales by leading product areas (%), 2006
- Krka, sales value (SIT bn) and growth (%), 2003-2006
- Zentiva, sales by leading markets (%), 2006
- Zentiva, sales by product groups (%), 2006
- Zentiva, sales value (CZK bn) and growth (%), 2003-2006
- Polpharma, sales by geographic coverage (%), 2006
- Polpharma, sales of APIs by geographic coverage (%), 2006
- Polpharma, sales value (PLN m) and growth (%), 2003-2006
- Sanitas, sales by leading markets (%), 2006
- Jelfa, sales of by type of medicine (%), H1 2007
- Sanitas, sales value (LTL m) and growth (%), 2003-2006
- Antibiotice, domestic and foreign sales (RON m), 2002-2006
- Antibiotice, sales by distribution channels (RON m), 2006
List of tables
- Basic economic and health indicators in CEE, 2006
- Biggest pharmaceutical companies in Central and Eastern Europe (revenue, net income, number of employees), 2006
- Russian pharmaceutical market, basic data, 2006
- Polish pharmaceutical market, basic data, 2006
- Czech pharmaceutical market, basic data, 2006
- Hungarian pharmaceutical market, basic data, 2006
- Romanian pharmaceutical market, basic data, 2006
- Ukrainian pharmaceutical market, basic data, 2006
- Bulgarian pharmaceutical market, basic data, 2006
- Croatian pharmaceutical market, basic data, 2006
- Slovakian pharmaceutical market, basic data, 2006
- Slovenian pharmaceutical market, basic data, 2006
- Lithuanian pharmaceutical market, basic data, 2006
- Latvian pharmaceutical market, basic data, 2006
- Estonian pharmaceutical market, basic data, 2006
- Serbian pharmaceutical market, basic data, 2006
- Currency rates used for calculation in the report
- Selected Central and Eastern European acquisition activity, 2006-2007
- Gedeon Richter, vital information, 2007
- Krka, vital information, 2007
- Zentiva, vital information, 2007
- Zentiva, sales by leading products, 2006
- Polpharma, vital information, 2007
- Sanitas, vital information, 2007
- Potential takeover targets, Central and Eastern European pharmaceuticals, 2007
- Leading Russian drug manufacturers by production volume, 2006
- Potential predators of regional CEE pharmaceutical manufacturers, 2007
Business strategies of pharma makers from Central and Eastern Europe 2007
Acquisition prospects and development forecasts
Choose your version of this product:
| Language / Licence | Single | 5 Users | Corporate | Global |
| English | 1600€ | 2400€ | 3200€ | 4000€ |
Compare licences
- - for the product preservation: saving the product in the memory of one computer belonging to the client;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for the individual use of one person only, who is indicated by the client during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of 2 to 5 computers belonging to the organisation indicated by the client while purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for 2 to 5 people who work for the organisation indicated by the client during purchasing process, and who are in the same country as the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in the same country as the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers can be located in or outside of the country of the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in or outside of the country of the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.